Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 55

    1.

    Food and Drug Administration approval of buprenorphine-naloxone for office treatment of addiction.

    Resnick RB.

    Ann Intern Med. 2003 Feb 18;138(4):360. No abstract available. PMID: 12585846 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Buprenorphine treatment of heroin dependence (detoxification and maintenance) in a private practice setting.

    Resnick RB, Galanter M, Resnick E, Pycha C.

    J Addict Dis. 2001;20(2):75-83.PMID: 11318399 [PubMed - indexed for MEDLINE]Related articles

    3.

    Analysis of the heel pad fat in rheumatoid arthritis.

    Resnick RB, Hudgins LC, Buschmann WR, Kummer FJ, Jahss MH.

    Foot Ankle Int. 1999 Aug;20(8):481-4.PMID: 10473057 [PubMed - indexed for MEDLINE]Related articles

    4.

    Heterotopic bone formation in male and female rabbits.

    Moed BR, Resnick RB, Fakhouri AJ, Nallamothu B.

    J South Orthop Assoc. 1998 Summer;7(2):86-9.PMID: 9665685 [PubMed - indexed for MEDLINE]Related articles

    5.

    Tibiotalar contact area and pressure distribution: the effect of mortise widening and syndesmosis fixation.

    Pereira DS, Koval KJ, Resnick RB, Sheskier SC, Kummer F, Zuckerman JD.

    Foot Ankle Int. 1996 May;17(5):269-74.PMID: 8734797 [PubMed - indexed for MEDLINE]Related articles

    6.

    Arthroscopic removal of an osteoid osteoma of the talus: a case report.

    Resnick RB, Jarolem KL, Sheskier SC, Desai P, Cisa J.

    Foot Ankle Int. 1995 Apr;16(4):212-5. Review.PMID: 7787980 [PubMed - indexed for MEDLINE]Related articles

    7.

    Deltoid ligament forces after tibialis posterior tendon rupture: effects of triple arthrodesis and calcaneal displacement osteotomies.

    Resnick RB, Jahss MH, Choueka J, Kummer F, Hersch JC, Okereke E.

    Foot Ankle Int. 1995 Jan;16(1):14-20. Erratum in: Foot Ankle Int 1995 May;16(5):314. PMID: 7697148 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effect of two nonsteroidal antiinflammatory drugs on heterotopic bone formation in a rabbit model.

    Moed BR, Resnick RB, Fakhouri AJ, Nallamothu B, Wagner RA.

    J Arthroplasty. 1994 Feb;9(1):81-7.PMID: 8163980 [PubMed - indexed for MEDLINE]Related articles

    9.

    Buprenorphine: an alternative to methadone for heroin dependence treatment.

    Resnick RB, Galanter M, Pycha C, Cohen A, Grandison P, Flood N.

    Psychopharmacol Bull. 1992;28(1):109-13.PMID: 1609035 [PubMed - indexed for MEDLINE]Related articles

    10.

    Buprenorphine responders: a diagnostic subgroup of heroin addicts?

    Resnick RB, Resnick E, Galanter M.

    Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(4):531-8.PMID: 1749829 [PubMed - indexed for MEDLINE]Related articles

    11.

    Psychological issues in the treatment of cocaine abuse.

    Resnick RB, Resnick E.

    NIDA Res Monogr. 1986;67:290-4. No abstract available. PMID: 3092080 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cocaine abuse and its treatment.

    Resnick RB, Resnick EB.

    Psychiatr Clin North Am. 1984 Dec;7(4):713-28.PMID: 6522310 [PubMed - indexed for MEDLINE]Related articles

    13.

    Methadone and naltrexone in the treatment of heroin dependence.

    Greenstein RA, Resnick RB, Resnick E.

    Psychiatr Clin North Am. 1984 Dec;7(4):671-9.PMID: 6522309 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare.

    Rawson RA, Washton AM, Resnick RB, Tennant FS Jr.

    Adv Alcohol Subst Abuse. 1984 Spring;3(3):41-9.PMID: 6093484 [PubMed - indexed for MEDLINE]Related articles

    15.

    Opiate withdrawal using lofexidine, a clonidine analogue with fewer side effects.

    Washton AM, Resnick RB, Geyer G.

    J Clin Psychiatry. 1983 Sep;44(9):335-7.PMID: 6355070 [PubMed - indexed for MEDLINE]Related articles

    16.

    Recent advances in opiate detoxification: clonidine and lofexidine.

    Washton AM, Resnick RB.

    NIDA Res Monogr. 1983 Apr;43:44-50. No abstract available. PMID: 6410276 [PubMed - indexed for MEDLINE]Related articles

    17.

    Addressing the diversion of take-home methadone: LAAM as the sole treatment choice for patients seeking maintenance therapy.

    Hough G, Washton AM, Resnick RB.

    NIDA Res Monogr. 1983 Apr;43:302-9. No abstract available. PMID: 6410265 [PubMed - indexed for MEDLINE]Related articles

    18.

    Lofexidine in abrupt methadone withdrawal.

    Washton AM, Resnick RB.

    Psychopharmacol Bull. 1982 Oct;18(4):220-1. No abstract available. PMID: 7156295 [PubMed - indexed for MEDLINE]Related articles

    19.

    Outpatient opiate detoxification with clonidine.

    Washton AM, Resnick RB.

    J Clin Psychiatry. 1982 Jun;43(6 Pt 2):39-41.PMID: 7085584 [PubMed - indexed for MEDLINE]Related articles

    20.

    Naltrexone and psychotherapy.

    Stone-Washton N, Resnick RB, Washton AM.

    NIDA Res Monogr. 1982 Apr;41:505-7. No abstract available. PMID: 6811941 [PubMed - indexed for MEDLINE]Related articles

    21.

    LAAM instead of take-home methadone.

    Resnick RB, Washton AM, Garwood J, Perzel J.

    NIDA Res Monogr. 1982 Apr;41:473-5. No abstract available. PMID: 6811936 [PubMed - indexed for MEDLINE]Related articles

    22.

    Patient self-adjustment of methadone maintenance dose.

    Resnick RB, Butler P, Washton AM.

    NIDA Res Monogr. 1982 Apr;41:327-30. No abstract available. PMID: 6811927 [PubMed - indexed for MEDLINE]Related articles

    23.

    Opiate detoxification using lofexidine.

    Washton AM, Resnick RB, Perzel JF, Garwood J.

    NIDA Res Monogr. 1982 Apr;41:261-3. No abstract available. PMID: 6811916 [PubMed - indexed for MEDLINE]Related articles

    24.

    Clonidine in opiate withdrawal: review and appraisal of clinical findings.

    Washton AM, Resnick RB.

    Pharmacotherapy. 1981 Sep-Oct;1(2):140-6.PMID: 6765486 [PubMed - indexed for MEDLINE]Related articles

    25.

    Clonidine vs. methadone for opiate detoxification: double-blind outpatient trials.

    Washton AM, Resnick RB.

    NIDA Res Monogr. 1981 Feb;34:89-94. No abstract available. PMID: 6783956 [PubMed - indexed for MEDLINE]Related articles

    26.

    Psychotherapy and naltrexone in opioid dependence.

    Resnick RB, Washton AM, Stone-Washton N.

    NIDA Res Monogr. 1981 Feb;34:109-15. No abstract available. PMID: 6783917 [PubMed - indexed for MEDLINE]Related articles

    27.

    Clonidine hydrochloride detoxification from methadone treatments: the value of naltrexone aftercare.

    Rawson RA, Washton AM, Resnick RB, Tennant FS Jr.

    NIDA Res Monogr. 1981 Feb;34:101-8. No abstract available. PMID: 6783916 [PubMed - indexed for MEDLINE]Related articles

    28.

    The clinical use of clonidine in outpatient detoxification from opiates.

    Washton AM, Resnick RB.

    Prog Clin Biol Res. 1981;71:277-84. No abstract available. PMID: 7330080 [PubMed - indexed for MEDLINE]Related articles

    29.

    Clonidine versus methadone for opiate detoxification.

    Washton AM, Resnick RB.

    Lancet. 1980 Dec 13;2(8207):1297. No abstract available. PMID: 6108466 [PubMed - indexed for MEDLINE]Related articles

    30.

    Clonidine for opiate detoxification: outpatient clinical trials.

    Washton AM, Resnick RB.

    Am J Psychiatry. 1980 Sep;137(9):1121-2. No abstract available. PMID: 7425173 [PubMed - indexed for MEDLINE]Related articles

    31.

    Clonidine for outpatient opiate detoxification.

    Washton AM, Resnick RB, Rawson RA.

    Lancet. 1980 May 17;1(8177):1078-9. No abstract available. PMID: 6103407 [PubMed - indexed for MEDLINE]Related articles

    32.

    Assessment of narcotic antagonists in the treatment of opioid dependence.

    Resnick RB, Schuyten-Resnick E, Washton AM.

    Annu Rev Pharmacol Toxicol. 1980;20:463-74. Review. No abstract available. PMID: 6992703 [PubMed - indexed for MEDLINE]Related articles

    33.

    Increased serum methadone levels in humans during naloxone-precipitated withdrawal [proceedings]

    Resnick RB, Washton A, Verebey K, Mule SJ.

    Psychopharmacol Bull. 1979 Apr;15(2):42-4. No abstract available. PMID: 432371 [PubMed - indexed for MEDLINE]Related articles

    34.

    Narcotic antagonists in the treatment of opioid dependence: review and commentary.

    Resnick RB, Schuyten-Resnick E, Washton AM.

    Compr Psychiatry. 1979 Mar-Apr;20(2):116-25. No abstract available. PMID: 421447 [PubMed - indexed for MEDLINE]Related articles

    35.

    Clonidine hydrochloride: a nonopiate treatment for opiate withdrawal.

    Washton AM, Resnick RB, Rawson RA.

    NIDA Res Monogr. 1979;27:233-9. No abstract available. PMID: 121339 [PubMed - indexed for MEDLINE]Related articles

    36.

    Clinical outcome with naltrexone.

    Resnick RB, Washton AM.

    Ann N Y Acad Sci. 1978;311:241-7. No abstract available. PMID: 283722 [PubMed - indexed for MEDLINE]Related articles

    37.

    Naltrexone in the treatment of opiate dependence.

    Resnick RB, Washton AM, Thomas MA, Kestenbaum RS.

    NIDA Res Monogr. 1978;(19):321-32. No abstract available. PMID: 218108 [PubMed - indexed for MEDLINE]Related articles

    38.

    Quantitative determination of benzoylecgonine and cocaine in human biofluids by gas-liquid chromatography.

    Kogan MJ, Verebey KG, DePace AC, Resnick RB, Mulé SJ.

    Anal Chem. 1977 Nov;49(13):1965-9. No abstract available. PMID: 907157 [PubMed - indexed for MEDLINE]Related articles

    39.

    Prospects, problems, side effects, and safety of narcotic antagonists.

    Resnick RB.

    Int J Addict. 1977 Oct;12(7):863-7.PMID: 591144 [PubMed - indexed for MEDLINE]Related articles

    40.

    Problems of methadone diversion and implications for control.

    Resnick RB.

    Int J Addict. 1977 Oct;12(7):803-6.PMID: 591140 [PubMed - indexed for MEDLINE]Related articles

    41.

    Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.

    Resnick RB, Kestenbaum RS, Washton A, Poole D.

    Clin Pharmacol Ther. 1977 Apr;21(4):409-13.PMID: 849672 [PubMed - indexed for MEDLINE]Related articles

    42.

    Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes.

    Resnick RB, Kestenbaum RS, Schwartz LK.

    Science. 1977 Feb 18;195(4279):696-8.PMID: 841307 [PubMed - indexed for MEDLINE]Related articles

    43.

    Short-term effects of naltrexone in 155 heroin ex-addicts.

    Volavka J, Resnick RB, Kestenbaum RS, Freedman AM.

    Biol Psychiatry. 1976 Dec;11(6):679-85.PMID: 999987 [PubMed - indexed for MEDLINE]Related articles

    44.

    Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes.

    Resnick RB, Kestenbaum RS, Schwartz LK.

    Psychopharmacol Bull. 1976 Oct;12(4):44-5. No abstract available. PMID: 972986 [PubMed - indexed for MEDLINE]Related articles

    45.

    A point of view concerning treatment approaches with narcotic antagonists.

    Resnick RB, Schuyten-Resnick E.

    NIDA Res Monogr. 1976 Sep;(9):84-7. No abstract available. PMID: 1004532 [PubMed - indexed for MEDLINE]Related articles

    46.

    Naltrexone: disposition, metabolism, and effects after acute and chronic dosing.

    Verebey K, Volavka J, Mulé SJ, Resnick RB.

    Clin Pharmacol Ther. 1976 Sep;20(3):315-28.PMID: 954353 [PubMed - indexed for MEDLINE]Related articles

    47.

    Evaluation of propranolol in opiate dependence.

    Resnick RB, Kestenbaum RS, Schwartz LK, Smith A.

    Arch Gen Psychiatry. 1976 Aug;33(8):993-7.PMID: 60091 [PubMed - indexed for MEDLINE]Related articles

    48.

    l-Alpha-acetylmethadol (LAAM): prognostic considerations.

    Resnick RB, Orlin L, Geyer G, Schuyten-Resnick E, Kestenbaum RS, Freedman AM.

    Am J Psychiatry. 1976 Jul;133(7):814-9.PMID: 937573 [PubMed - indexed for MEDLINE]Related articles

    49.

    Letter: Treatment of accidental naltrexone-induced withdrawal.

    Volavka J, Resnick RB.

    Am J Psychiatry. 1976 Feb;133(2):233. No abstract available. PMID: 56139 [PubMed - indexed for MEDLINE]Related articles

    50.

    Studies of EN-1639A (naltrexone): a new narcotic antagonist.

    Resnick RB, Volavka J, Freedman AM, Thomas M.

    Am J Psychiatry. 1974 Jun;131(6):646-50. No abstract available. PMID: 4827793 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...